WuXi NextCODE racks up $240 mln Series B
WuXi NextCODE, the global platform for genomic data, has closed $240 million in Series B financing. The investors included Sequoia China, Temasek, Yunfeng Capital, 3W Partners, Temasek, Yunfeng, 3W and Amgen Ventures. China Renaissance Group provided financial advice to WuXi NextCODE on the transaction.
7 September 2017•1 min read
